Latest News about biotech
Recent news which mentions biotech
FDA Approves Exelixis' Lead Cancer Drug Cabometyx For Expanded Use In Neuroendocrine Tumors
March 26, 2025
From Benzinga
FDA Approves GSK's Oral Antibiotic For Urinary Tract Infections For Females Aged 12 Years And Older
March 26, 2025
From Benzinga
Wave Life Sciences Stock Jumps On Positive Data From Muscle Disorder Drug, Plans FDA Submission Next Year
March 26, 2025
From Benzinga
Eli Lilly, Palo Alto Networks Traders Take Note: Direxion's New Leveraged ETFs Are Here
March 26, 2025
From Benzinga
Eli Lilly, Palo Alto Networks Traders Take Note: Direxion's New Leveraged ETFs Are Here
March 26, 2025
From Benzinga
Humacyte Shares Plunge After Hours: Here's Why
March 25, 2025
From Benzinga
Avalo Therapeutics 'Represents An Attractive Pure-Play,' Analyst Initiates Coverage With Over 300% Stock Upside
March 25, 2025
From Benzinga
Crinetics Pharmaceuticals Analyst Sees Around 70% Upside For Stock, Cites More Investor Interest In Endocrinology
March 25, 2025
From Benzinga
Merck Partners With Hengrui Pharma In $1.77 Billion Deal For Cardiovascular Treatment
March 25, 2025
From Benzinga
From Benzinga
Axsome Therapeutics Lower Dose Of Attention Deficient Disorder Candidate Hits Primary Goal
March 25, 2025
From Benzinga
Cassava Sciences Discontinues Developing Simufilam For Alzheimer's After Another Phase 3 Trial Flop
March 25, 2025
From Benzinga
Kezar Life Sciences Touts Positive Data From Mid-Stage Study For Chronic Liver Disease Drug Candidate
March 25, 2025
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
